NCT01402687
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
NCT01402687
NCT00871702
NCT01440556
NCT01371227
NCT00807677
NCT00090493
NCT01149668
NCT01801436
Not specified
NCT01292486
NCT00346255